CompletedEarly Phase 1ketamine
EEG Characteristics in ECT
Sponsored by University of New Mexico
NCT ID
NCT04022226
Target Enrollment
11 participants
Start Date
2019-10-01
Est. Completion
2020-10-01
About This Study
The investigators will be examining slow-wave characteristics in depressed patients receiving electroconvulsive therapy (ECT) using direct current electroencephalogram (dcEEG) by anesthesia induction agent.
Conditions Studied
Interventions
- •Ketamine
- •Methohexital
Eligibility
Age:18 Years - 65 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria: * Structured Clinical Interview for DSM-5 will confirm diagnosis of MDD or BPD-depressed (with or without psychotic features * The clinical indications for ECT including treatment resistance or a need for a rapid and definitive response; * Hamilton Depression Rating Scale 24-item (HDRS-24) \> 21; and * Age range between 18 and 65 years of age. Exclusion Criteria: * Defined neurological or neurodegenerative disorder (e.g., history of head injury with loss of consciousness \> 5 minutes, epilepsy, Alzheimer's disease); * Other psychiatric conditions (e.g., schizophrenia, schizoaffective disorder, bipolar disorder) * Current drug or alcohol use disorder, except for nicotine and marijuana * Adults unable to consent, pregnant women, prisoner * Non-English speakers * Patients that cannot tolerate Methohexital and Ketamine.
Study Locations (1)
University of New Mexico Mental Health Center
Albuquerque, New Mexico, United States